Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
暂无分享,去创建一个
U. Vaishampayan | M. Cher | D. Sbrissa | S. Chinni | B. Govindarajan | Mark F. Pressprich | Seong-Jm Kim
[1] Hong Liang,et al. Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer. , 2021, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Hancock,et al. Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity , 2021, Nature Communications.
[3] L. Fong,et al. How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer , 2021, Prostate Cancer and Prostatic Diseases.
[4] Ash A. Alizadeh,et al. Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx. , 2020, Methods in molecular biology.
[5] Ash A. Alizadeh,et al. Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.
[6] A. Shisheva,et al. A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells. , 2018, Oncogene.
[7] E. Heath,et al. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis , 2016, Molecular Cancer.
[8] P. De Camilli,et al. The leukodystrophy protein FAM126A/Hyccin regulates PI4P synthesis at the plasma membrane , 2015, Nature Cell Biology.
[9] I. Keklikoglou,et al. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. , 2015, Cancer research.
[10] T. Balla,et al. EFR3s are palmitoylated plasma membrane proteins that control responsiveness to G-protein-coupled receptors , 2015, Journal of Cell Science.
[11] H. Weng,et al. CXCR4 over-expression and survival in cancer: A system review and meta-analysis , 2014, Oncotarget.
[12] T. Balla,et al. A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi , 2014, The Journal of cell biology.
[13] G. Wang,et al. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway , 2014, Medical Oncology.
[14] Sang Yoon Lee,et al. PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity , 2012, The Journal of cell biology.
[15] P. Rolland,et al. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer , 2012, British Journal of Cancer.
[16] T. Sparwasser,et al. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer , 2012, Oncoimmunology.
[17] K. Pienta,et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.
[18] S. Sánchez-Ramón,et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. , 2011, Blood.
[19] S. Sheng,et al. Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells. , 2010, Translational oncology.
[20] S. Jee,et al. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway. , 2009, Carcinogenesis.
[21] S. Emr,et al. Assembly of the PtdIns 4-kinase Stt4 complex at the plasma membrane requires Ypp1 and Efr3 , 2008, The Journal of cell biology.
[22] Liang Zhao,et al. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway , 2008, British Journal of Cancer.
[23] T. Kume,et al. Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. , 2008, Biochemical and biophysical research communications.
[24] M. Cher,et al. CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone , 2008, Molecular Cancer Research.
[25] D. Carbone,et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.
[26] K. Shokat,et al. Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. , 2007, Molecular biology of the cell.
[27] Stephen L. Abrams,et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. , 2007, Biochimica et biophysica acta.
[28] M. Ratajczak,et al. The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis , 2006, Leukemia.
[29] T. Balla,et al. Phosphatidylinositol 4-kinases: old enzymes with emerging functions. , 2006, Trends in cell biology.
[30] T. Kipps,et al. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.
[31] D. Jonas,et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. , 2006, Neoplasia.
[32] Xiyun Deng,et al. CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12 , 2006, The Prostate.
[33] A. Abdel‐Mageed,et al. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. , 2005, Cancer research.
[34] P. Várnai,et al. A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. , 2005, Molecular biology of the cell.